Rheumatic disorders in children, like juvenile arthritis and lupus, can damage joints and organs if untreated. Early ...

While arthritis is more commonly known to affect older people, it can occur in youngsters too. We speak to the father of one ...

Arthritis (bone problems) can affect the entire body structure. It is usually known as a problem that occurs with aging, but ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

Doctors also prescribe Xeljanz for certain children ages 2 years and older who have polyarticular juvenile idiopathic arthritis (JIA ... and causes pain and other symptoms.

Remission refers to having few or no UC symptoms. You’ll take an induction ... is approved to treat polyarticular course juvenile idiopathic arthritis in children ages 2 years and older.

It’s reassuring to know that there are several effective treatments to manage disease activity and relieve symptoms of juvenile idiopathic arthritis (JIA). But for many parents, that comfort is offset ...

Rheumatic disorders, conditions caused by a dysregulated immune system, are prevalent among neonates and children. Speaking ...

Tuberculous and juvenile idiopathic arthritis–associated uveitis were common etiologies ... we found that patients with recurrent clinical symptoms, despite treatment, as well as those exhibiting ...

As any doctor can tell you, treating a child is not the same as treating an adult. Nor are juvenile idiopathic arthritis (JIA) and other pediatric rheumatic diseases the same as the adult rheumatic ...